Add as a preferred source on GoogleLunai Bioworks Plans Nasdaq Delisting After $9.02 Million Deficit
Trading in its common stock is expected to be suspended Oct. 30, with the delisting expected to take effect around Nov. 12.
Lunai Bioworks Inc. (LNAI) plans to delist from Nasdaq after the exchange determined it failed the $2.5 million stockholders’ equity requirement, with trading in its common stock expected to be suspended at the opening of business Friday, Oct. 30.
Lunai had a stockholders’ deficit of $9.02 million as of June 30, 2026. Nasdaq’s minimum equity threshold is $2.5 million.
The company plans to file Form 25 with the Securities and Exchange Commission around Nov. 2. The delisting is expected to take effect around Nov. 12.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.